Development of Dissolution Test Method for Buflomedil Hydrochloride Tablets and Ticlopidine Hydrochloride Tablets |
Lee, Ryun-Kyung
(Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration)
Jeong, Gyeong-Rok (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Oh, Hyun-Sook (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Shim, Jee-Youn (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Suh, Sang-Chul (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Lee, Hyo-Jung (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Kim, Min-A (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Park, Seong-Min (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Lee, Kyu-Ha (National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex) Sohn, Kyung-Hee (National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex) Kim, In-Kyu (National Institute of Food and Drug Safety Evaluation, Osong Health Technology Administration Complex) Sah, Hong-Kee (College of Pharmacy, Ewha Womans University) Choi, Hoo-Kyun (College of Pharmacy, Chosun University) Cho, Tae-Yong (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) Hong, Choong-Man (Hazardous Substances Analysis Division, Daegu regional Korea Food & Drug Administration) |
1 | 대한약전 9개정 : 경구용의약품의 용출규격 설정 지침 (2007). |
2 | 식품의약품안전청 고시 : 의약품동등성시험관리규정 (2005). |
3 | 대한약전 9개정 : 의약품등 분석법의 밸리데이션에 대한 지침 (2007). |
4 | McTavish, D., Faulds, D. and Goa, K. L. : An updated review of its pharmacology and therapeutic use in platelet dependent disorders. Drugs 40, 238 (1990). |
5 | Handin, R. I. : Disorders of the platelet and wessel wall. In: Fauci, A. S., Braunwald, E., Isselbacher, K. J. Harrisons principle of internal medicine. 14th ed. New York, NY: McGraw-Hill Book Co 735 (1998). |
6 | Yu, K. H., Lee, B. C., Kwon, K. H., Song, H. K. and Kim, S. M. : The inhibitory effect of ticlopidine to platelets aggregation. J. Korean Neurol. Assoc. 12, 436 (1994). |
7 | Haas, W. K., Easton, J. D. and Adams, H. P. : A randomized trial comparing ticlopidine hydrochloride with aspirine for prevention of stroke in high-risk patients. N. Engl. J. Med. 321, 501 (1989). |
8 | Lanzon, L., Bergqvist, D., Boberg, J., Boberg, M., Eriksson, I., Lindgarde, F. and Persson, G. : Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicenter Study. J. Intern. Med. 227, 301 (1990). |
9 | Symeonidis, A., Kouraklis-Symeonidis, A., Seimeni, U., Galani, A., Giannakoulas, N., Fragopanagou, E., Tiniakou, M., Matsouka, P. and Zoumbos, N. : Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional case. Am. J. Hematol. 71, 24 (2002). |
10 | 식품의약품안전청 : 대한약전외 의약품등 기준 제 3개정 (2007). |